Global Medical Cyclotron Market Analysis
Overview
A medical cyclotron is a sort of particle accelerator that is used to diagnose and cure chronic diseases including cancer, heart disease, and others. A cyclotron is a device that uses a magnet and an enhanced power voltage to spirally accelerate charged particles. When a particle collides with a target, a nuclear reaction occurs, resulting in the production of a radioactive isotope. As a result, a medical cyclotron might also be referred to as an isotope generator.
These isotopes are then mixed with chemical molecules (mainly glucose) to generate injectable radioactive tracers that may be utilized in PET scans and other surgical tests. In a PET scan, a radioactive tracer is injected into the patient’s body. PET imaging techniques are used by clinicians to identify the presence of a radioactive substance at specific locations in the body. When the PET scan is utilized in cancer diagnosis, cancerous cells combine this isotope with glucose as a source of energy. In PET scan pictures, rapidly developing cancer cells appear as a glow, confirming the presence of malignant cells at the afflicted spot.
Get Sample PDF Brochure with Impact of COVID19
Since radioactive isotopes have a short half-life (e.g., Flourine-18 has a half-life of around 110 minutes), they decay quickly after being created. As a result, several research and diagnostic institutions have built their own medical cyclotrons to create radioactive isotopes for a variety of medical uses.
Drivers
Cancer’s high incidence is projected to be a significant factor driving the global medical cyclotron market forward. This is owing to the medical cyclotron’s capacity to diagnose cancer, monitor therapy response, and screen for disease recurrence utilizing PET scan procedures. As per a factsheet published by the World Health Organization (WHO) in February, cancer is the world’s largest non-communicable illness and the second leading cause of death. Furthermore, according to a report published by the International Agency for Research on Cancer (IARC) in 2012, about 14.1 million new instances of cancer were diagnosed in 2012, with approximately 8.8 million deaths. According to the research, about 32.6 million individuals are diagnosed with cancer.
Furthermore, PET scans are frequently used in the diagnosis of cardiovascular illnesses as well as diseases of the central nervous system, such as Alzheimer’s and Parkinson’s disease. The rising rate of these illnesses is a significant reason driving up demand for PET scans for diagnostic purposes, which is likely to drive the global medical cyclotron market forward.
PET scans can assist precision medicine and nuclear medicine in the treatment of chronic diseases all over the world, which would help the medical cyclotron industry. In-house medical cyclotrons are increasingly being used by academic research sites to improve nuclear medicine and radiochemistry research. The University of Chicago opened a new cyclotron research facility on campus in January 2017 to help researchers.
Buy This Research Study Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/2039
Restraints
Medical cyclotrons, on the other hand, need a significant financial commitment, limiting their usage to only a few end users. Furthermore, the global medical cyclotron market’s expansion may be hampered by the lack of commercially available isotopes with extended half-lives.
Regional Analysis
The global medical cyclotron market is expected to be dominated by North America. The U.S. also has one of the highest cancer rates in the world, implying a higher demand for PET scans and, eventually, medical cyclotrons. As per the American Cancer Society, cancer was the second largest cause of death in 2018, after only cardiovascular disease. Moreover, the study estimated 1.7 million new cancer diagnoses and half a million cancer-related deaths. Due to the increasing frequency of cancer, demand for PET scans is projected to rise, propelling the market forward. According to the Centers for Disease Control and Prevention (CDC), around 2 million PET scans are performed in the U.S. each year.
The increased proportion of non-communicable illnesses in Asia Pacific’s rising countries is projected to drive up healthcare spending in the region, as well as the use of nuclear medicine and its adaption. In 2017, the International Atomic Energy Agency (IAEA) partnered with the European Association of Nuclear Medicine (EANM) to provide training courses, instructional resources, and high-quality facilities for nuclear medicine and hybrid imaging specialists.
To get detailed table of content (ToC), please click – https://www.coherentmarketinsights.com/ongoing-insight/toc/2039
Competitive Landscape
Major companies contributing in the global medical cyclotron market are Siemens Healthineers USA, Inc., Advanced Cyclotron Systems, Inc., IBA, Best Cyclotron Solutions Inc., GE Healthcare, and Sumitomo Heavy Industries, Ltd.,
To increase their market share, key companies are focusing on releasing innovative and dependable medical cyclotron products. At the 2016 Society of Nuclear Medicine and Molecular Imaging annual meeting in San Diego, California, IBA unveiled Cyclone KIUBE. It is a cost-effective 18 MeV fixed energy cyclotron with a small design that allows for the synthesis of nearly all radioisotopes.
Table of Content
Global Medical Cyclotrons Market Research Report
Section 1: Global Medical Cyclotrons Industry Overview
Section 2: Global Economic Impact on Medical Cyclotrons Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Medical Cyclotrons Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Medical Cyclotrons Market Forecast
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837